REFERENCES

1. Hoit BD, Wright FL. Left Atrial Remodeling. 2017;10–2.
2. A G. EHRA/HRS/APHRS/SOLEAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Heart Rhythm. 2017;14:e3–40.
3. Zoppini G, Bonapace S, Bergamini C, et al. Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function. Nutr Metab Cardiovasc Dis. 2016;26(11):1026–32.
3. Ning SBG, Hiam MT, All FF, et al. Revue générale Le diabète sucré en Afrique subsaharienne: aspects épidémiologiques, difficultés de prise en charge. 2007;607–11.
5. Douglas PS. The left atrium. J Am Coll Cardiol. 2003;42(7):1206–7.
6. Réant P. Analyse échocardiographique des déformations myocardiques en speckle tracking. Bordx Univ Bordx. 2009;220.
7. Mohamed G, Mamdouh AM. Early Detection of Left Atrial Dysfunction by Speckle Tracking Echocardiography in Hypertensive Patients with Normal Left Atrial Size. Egypt J Hosp Med. 2016;63:143–56.
8. Georgievska-Ismail L, Zafirovska P, Hristovski Z. Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction. Diab Vasc Dis Res. 2016;13(6):384–94.
9. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph. J Am Soc Echocardiogr. 2005;18(12):1440–63.
10. Gulmez O, Parıldar H, Cigerli O, et al. General Medicine : Open Access Assessment of Left Atrial Functions in Patients with Prediabetes. 2017;5(5).
11. Meel R, Khandheria BK, Peters F, et al. Left atrial volume and strain parameters using echocardiography in a black population. 2016;1:1–6.
12. Wentworth D, Stamler J, The FOR, et al. age-groups (1-6). Generally, CVD ac-. 1993;16(2):434–44.
13. Esh H, Agabiti E, France MA, et al. 2018 ESC / ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology ( ESC ) and the European Society of. 2018. 1-98 p.
14. Bounhoure J, Komajda M. Cardiomyopathie Diabétique : une entité spécifique ? 2017;325–37.
15. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10(2):165–93.
16. Meuleman C, Dufaitre G, Haddour N, et al. Mesure échographique de l ’ oreillette gauche : diamètre , surface ou volume ? d:3–5.
17. Markman TM, Habibi M, Ambale-Venkatesh B, et al. Left atrial structure and function and cardiovascular events in patients with diabetes mellitus: Results from multi-ethnic study of atherosclerosis (MESA). Vol. 130, Circulation. 2014. p. 1–7.
18. Asbun J, Villarreal FJ. The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy. J Am Coll Cardiol. 2006;47(4):693–700.
19. Muranaka A, Yuda S, Tsuchihashi K, et al. Quantitative assessment of left ventricular and left atrial functions by strain rate imaging in diabetic patients with and without hypertension. Echocardiography. 2009;26(3):262–71.
Table I: Baseline characteristics, diabetes and cardiovascular risk factors’ characteristics